Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$24.71M$24.71Mderived+13.8% vs Q4 2019 Net Income$10.67M$10.67Mderived+1,225.5% vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$14,996,000+15.8% Operating Incomederived$1,035,000−21.1% Operating Cash Flowderived$7,612,000+75.4% Free Cash Flowderived$7,383,000+160.9% Margins · derivedGross margin60.7%+1.0 pt vs Q4 2019
Operating margin4.2%−1.9 pt vs Q4 2019
Net margin43.2%+39.5 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 22, 2021 · 81 d after period end